- Home
- Healthcare professionals
- ACE Technology Guidances
- Drug Guidance
- Review of cancer drugs for prostate cancer
Withdrawn
Review of cancer drugs for prostate cancer
13 September 2024
Published on 04 Jan 2022
Last Updated on 13 Sep 2024
Review of cancer drugs for prostate cancer Guidance is outdated and has been withdrawn on 13 Sep 2024.
Review of cancer drugs for prostate cancer (Withdrawn 13 Sep 2024) [PDF, 194 KB]
PES Treatments for advanced prostate cancer (Updated 19 Dec 2022) [PDF, 99 KB]